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Objective: HLA-C*03:36, -C*03:56 and -C*03:86 are three human leukocyte antigen type C (HLA-C) locus
alleles that are rarely observed in the Taiwanese population. The objective of this study is to report the
three plausible deduced HLA haplotypes in association with C*03:36, C*03:56, and C*03:86 in Taiwanese
unrelated bone marrow stem cell donors.
Materials and Methods: The sequence-based typing method was used to conﬁrm the low-incidence
alleles observed. Polymerase chain reaction was carried out to amplify exons 2 and 3 of the HLA-C
locus with group-speciﬁc primer sets. Amplicons were sequenced using the BigDye Terminator Cycle
Sequencing Ready Reaction Kit in both directions according to the manufacturer’s protocol.
Results: We conﬁrmed the DNA sequences of C*03:36, C*03:56, and C*03:86 and deduced the three
plausible HLA haplotypes in association with C*03:36 (A*33:03-B*58:01-C*03:36-DRB1*01:01), C*03:56
(A*02:01-B*48:01-C*03:56-DRB1*12:02), and C*03:86 (A*02-B*35-C*03:86-DRB1*09:01) in unrelated
Taiwanese bone marrow stem cell donors.
Conclusion: The three uncommon HLA-C haplotypes that we provide here are valuable for HLA tissue-
typing laboratories for reference purposes and for stem cell transplantation donor search coordinators
to determine the likelihood of ﬁnding compatible donors in unrelated bone marrow donor registries for
patients bearing these three uncommon HLA-C locus alleles.
Copyright  2013, Buddhist Compassion Relief Tzu Chi Foundation. Published by Elsevier Taiwan LLC. All
rights reserved.1. Introduction
With the advent of molecular typing methodology, the numbers
of alleles being unveiled at various human leukocyte antigen (HLA)
loci are steadily increasing [1]. Results of many studies have shown
that HLA allelic polymorphism among different ethnic groups and
racial populations is widely observed and the patterns of linkage
disequilibrium among various alleles differ signiﬁcantly among
human populations [2e5]. Clinically speaking, HLA matching has a
great impact on the success of organ and tissue transplants.
Therefore, persistent efforts to reveal de novo alleles in population
worldwide have continued to meet stringent compatibility re-
quirements for bone marrow stem cell donors and recipients.tics, Tzu Chi Cord Blood Bank




ddhist Compassion Relief Tzu ChiSimilarly, determination of haplotypes is essential for matching
unrelated hematopoietic stem cell transplantation donors and re-
cipients, because matching at the haplotype level has a better
likelihood of matching at other loci within the HLA region than
matching only at the individual allelic level.
The population of Taiwan consists of four major groups, namely,
the Min Nan, Hakka, aborigines, and Chinese mainlanders [6]. Thus,
the database of our hematopoietic stem cell registry comprises
volunteer donors with HLA alleles and haplotypes that have unique
characteristics. We have discovered new alleles, rare frequency al-
leles, and Taiwanese conserved alleles and haplotypes in our
routine HLA typing studies [4,5,7].
The HLA-C genes contain eight exons. Polymorphism in exons 2
and 3 encodes proteins that are responsible for peptide-binding
speciﬁcity. DNA sequence typing for this polymorphism is
routinely performed for bone marrow stem cells and kidney
transplantation. Many alleles in the HLA-C locus show character-
istic linkage disequilibrium with HLA-B alleles in the Taiwanese
population [5]. In particular, C*01:02 is linked with B*46:01,Foundation. Published by Elsevier Taiwan LLC. All rights reserved.
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C*03:02, and C*08:01 have also been found to be associated with
B*55:02, B*40:01, and B*40:06, respectively [5]. The patterns of
linkage disequilibrium as such provide a useful reference tool for
selecting potential donors in HLA conﬁrmatory testing and may
also be used when specimen mix-up is suspected.
HLA-C*03:36, -C*03:56, and -C*03:86 were ﬁrst reported to the
international ImMunoGeneTics project/HLA (IMGT/HLA) database
in 2007, 2009, and 2010, respectively (http://www.ebi.ac.uk/cgi-
bin/imgt/hla/ethnicity.cgi). In this article, we describe the HLA
haplotypes in association with HLA-C*03:36, -C*03:56, and
-C*03:86 alleles found in ﬁve Taiwanese individuals and propose a
likelihood-based approach on how the alleles maybe derived.
2. Materials and methods
Peripheral whole blood samples from bone marrow donors
with Min Nan Taiwanese ethnicity were collected in acid citrate
dextrose (ACD) anticoagulant. Formal written consents were
signed by the donors before any blood collection. ACD whole
blood was stored at 80C until use. Genomic DNA was extracted
using the QIAamp DNA Blood Mini Kit according to the manu-
facturer’s instructions (Qiagen, Hilden, Germany). Genomic DNA
typing of HLA-A, -B, -C, and -DRB1 loci were ﬁrst performed using
the Dynal Reli sequence-speciﬁc oligonucleotide (SSO) probe HLA-
A, -B, -C, and -DRB1 Typing Kits (Dynal Biotech, Bromborough,
Wirral, UK), followed by the sequence-speciﬁc primer (SSP) typing
method (AllSet Gold SSP HLA high-resolution kits; Dynal Biotech,
Invitrogen, Brown Deer, WI, USA) to reach high-resolution allelic
subtypes. The sequence-based typing (SBT) method [8] was used
to conﬁrm the low-incidence alleles observed, and in cases of
anomalous results and typing ambiguities from the SSO or SSP
typing protocols. Polymerase chain reaction was carried out to
amplify exons 2 and 3 of the HLA-C locus with group-speciﬁc
primer sets as previously described [8]. Amplicons were
sequenced by the BigDye Terminator Cycle Sequencing ReadycDNA    350        360      370        380     390
C*01:02:01 GGTCTCA CACCCTCCAG TGGATGTGTG GCTGCGACCT GGGGCCCGAC
C*03:02:01 ------- --T------- A------A-- --------G- ----------
C*03:03:01 ------- --T-A----- A------A-- --------G- ----------
C*03:36  ------- --T------- A------A-- --------G- ----------
C*03:56  ------- --T-A----- A------A-- --------G- ----------
C*03:86  ------- ---------- ---------- ---------- ----------
cDNA       450       460         470          480         
C*01:02:01 CATCGCCCTG AACGAGGACC TGCGCTCCTG GACCGCCGCG GACACCG
C*03:02:01 ---------- --------T- ---------- ---------- -----G-
C*03:03:01 ---------- --------T- ---------- ---------- -----G-
C*03:36  ---------- --------T- ---------- ---------- -----G-
C*03:56  ---------- --------T- ---------- ---------- -----G-
C*03:86  ---------- ---------- ---------- ---------- -------
cDNA       550      560          570      580    
C*01:02:01 AGAGCCTACC TGGAGGGCAC GTGCGTGGAG TGGCTCCGCA GATACCT
C*03:02:01 ---------- --------CT ---------- ---------- -------
C*03:03:01 ---------- --------CT ---------- ---------- -------
C*03:36  ---------- --------CT ---------- ---------- -------
C*03:56  ---------- --------CT ---------- ---------- -------
C*03:86  ---------- ---------- ---------- ---------- -------
In exon 3, from nucleotide 344 to nucleotide 619, the DNA sequence of C*03:86 is id
C*03:36 is identical to C*03:02:01 except at the position 527 (A->T; shaded). The DNA
of exon 3 (A->T; shaded). 
Fig. 1. Comparison of exon 3 nucleotide sequences between C*01:02:01, C*03:02:0Reaction Kit (Applied Biosystems, Foster City, CA, USA) in both
directions.
3. Results
We conﬁrmed that the DNA sequence of C*03:36 is analogous to
the sequence of C*03:02:01 in exons 2 (data not shown) and 3,
except for the nucleotide at position 527, inwhich A is replaced by T
(Fig. 1). The nucleotide replacement caused an amino-acid ex-
change from E to V at residue 152. In exons 2 (data not shown) and
3, the DNA sequence of C*03:56 is identical to the sequence of
C*03:03:01 except for the nucleotide at residue 434, in which A is
replaced by T (Fig. 1). The nucleotide substitution generated an
amino-acid replacement from K to M at codon 121. Similarly, the
DNA sequence of C*03:86 is identical to the sequence of C*03:03:01
in exon 2 (data not shown). In exon 3, the sequence of C*03:86 is
identical to C*03:03:01 from the nucleotide at position 344 to po-
sition 352, whereas the rest of the sequence in exon 3 (from posi-
tion 353 to position 619) is identical to the sequence of C*01:02:01
(Fig. 1).
The extended HLA typing of the two unrelated Taiwanese bone
marrow stem cell donors carrying C*03:36 was A*02:07, A*33:03,
B*46:01, B*58:01, C*01:02, C*03:36, DRB1*01:01, and DRB1*15:01,
and A*11:01, A*33:03, B*40:01, B*58:01, C*07:02, C*03:36,
DRB1*01:01, and DRB1*12:02. Together with the typing informa-
tion about the three HLA haplotypes reported to the IMGT/HLA
database (http://www.ebi.ac.uk/cgi-bin/imgt/hla/ethnicity.cgi), the
plausible HLA-A, -B, and -DRB1 haplotype in association with
C*03:36 in Taiwanese population may be deduced as A*33:03-
B*58:01-C*03:36-DRB1*01:01 (Table 1). Because B*58:01 is
frequently observed to associate with C*03:02 in Taiwanese pop-
ulation [5], we think the haplotype A*33:03-B*58:01-C*03:36-
DRB1*01:01 may have been derived from A*33:03-B*58:01-
C*03:02-DRB1*01:01.
The extended HLA typing of the unrelated Taiwanese bone
marrow donor carrying C*03:56 was A*02:01, B*13:01, B*48:01,          400          410         420          430         440  
 GGGCGCCTCC TCCGCGGGTA TGACCAGTAC GCCTACGACG GCAAGGATTA  
 ---------- ---------- --------C- ---------- ----------  
 ---------- ---------- ---------- ---------- ----------  
 ---------- ---------- --------C- ---------- ----------  
 ---------- ---------- ---------- ---------- ---T------  
 ---------- ---------- ---------- ---------- ----------  
490          500          510         520         530          540 
CGG CTCAGATCAC CCAGCGCAAG TGGGAGGCGG CCCGTGAGGC GGAGCAGCGG  
--- ---------- ---------- ---------- ---------- --------T-  
--- ---------- ---------- ---------- ---------- --------T-  
--- ---------- ---------- ---------- ------T--- --------T-  
--- ---------- ---------- ---------- ---------- --------T-  
--- ---------- ---------- ---------- ---------- ----------  
590          600          610        619    
GGA GAACGGGAAG GAGACGCTGC AGCGCGCGG  
-A- ---T------ ---------- ---------  
-A- ---T------ ---------- ---------  
-A- ---T------ ---------- ---------  
-A- ---T------ ---------- ---------  
--- ---------- ---------- --------- 
entical to the sequence of C*01:02:01 (shaded). In exon 3, the sequence of 
 sequence of C*03:56 is identical to C*03:03:01 except at the residue 434
1, C*03:03:01, C*03:36, C*03:56, and C*03:86. cDNA ¼ complementary DNA.
Table 1
HLA haplotype of donors with HLA-C*03:36 (A*33:03-B*58:01-C*03:36-
DRB1*01:01).
Donor HLA-A* HLA-B* HLA-C* HLA-DRB1*
1 02:07 46:01 01:02 15:01
33:03 58:01 03:36 01:01
2 11:01 40:01 07:02 12:02
33:03 58:01 03:36 01:01
HC18734 02:03 38:02 07:02 16:02
33:03 58:VE 03:36 01:01
HC14742 02:01 39:01 07:02 13:01
33:03 58:01 03:36 01:01
HC23497 33 58CNSX 03:02 03:01
33 58CNSX 03:36 01:01
HLA ¼ human leukocyte antigen.
Table 3
HLA haplotype of donors with HLA-C*03:86 (A*02-B*35-C*03:86-DRB1*09:01).
Donor HLA-A* HLA-B* HLA-C* HLA-DRB1*
1 02 46 01:02 04
02 35 03:86 09:01
2 24:02 58:01 03:02 04:05
02:06 35:01 03:86 09:01
HC21208 02 15:DAFZ 04:FEAS 11:01
02 35:DHXM 03:86 09:01
HLA ¼ human leukocyte antigen.
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Together with the HLA information about the cell carrying C*03:56
listed on the IMGT/HLA database, the probable HLA haplotype of
the Taiwanese unrelated donor bearing C*03:56 may be deter-
mined as A*02:01-B*48:01-C*03:56-DRB1*12:02 (Table 2).
The extended HLA typing of the two unrelated Taiwanese do-
nors carrying C*03:86 was A*02, B*35, B*46:01, C*01:02, C*03:86,
DRB1*04, and DRB1*09:01, and A*02:06, A*24:02, B*35:01, B*58:01,
C*03:02, C*03:86, DRB1*04:05, and DRB1*09:01. Taking into the
account the HLA typing reported to the IMGT/HLA database and the
HLA databases that we established previously [4,5,9,10], the plau-
sible HLA-A, -B, -C, and -DRB1 haplotype associatedwith C*03:86 in
the two Taiwanese unrelated donors may be deciphered as A*02-
B*35-C*03:86-DRB1*09:01 (Table 3).
We believe the probable HLA haplotypes associated with
C*03:36, C*03:56, and C*03:86 that we deduced are highly likely
because the frequencies of the alleles are very low in randomized
unrelated donors and are represented in at least two unrelated
donors that were investigated by independent HLA laboratories.
4. Discussion
C*03:36 and C*03:56 were probably derived from C*03:02:01
and C*03:03:01, respectively, as a result of a nucleotide substitu-
tion.We speculate the allele C*03:86wasmost likely derived from a
DNA recombination event, similar to the formations of HLA-
B*35:87 [11] and HLA-B* 44:150 [12], between alleles C*03:03:01
and C*01:02:01. In the hypothesized recombination episode,
C*03:03:01 received a segment of a DNA sequence from C*01:02:01
consisting of at least the sequence from residue 353 to residue 619
(Fig. 1). Our theory is based on the observation that the sequence of
C*03:86 is identical to the sequence of C*01:02:01 from position
353 to position 619 (Fig. 1).
Over 100 HLA-C*03 alleles are presently listed in the IMGT/HLA
database. In Taiwanese populations, C*03 is the most commonly
detected HLA-C allele (23.31%), followed by C*01 (22.06%), C*07
(21.36%), C*08 (10.32%), C*04 (6.77%), C*06 (5.52%), C*14 (3.56%),
C*15 (3.34%), C*12 (3.03%), C*05 (1.78%), and C*17 (1.78%). The HLA-
C*03 variant alleles detected in Taiwanese population are C*03:04,Table 2
HLA haplotype of donors with HLA-C*03:56 (A*02:01-B*48:01-C*03:56-
DRB1*12:02).
Donor HLA-A* HLA-B* HLA-C* HLA-DRB1*
1 02:01 13:01 03:04 01:01
02:01 48:01 03:56 12:02
HC18244 24:CWTG 51:CSSF 14:02 13:02
02:CWTF 48:HCP 03:56 12:CVT
HLA ¼ human leukocyte antigen.C*03:02, and C*03:03 with a frequency of 11.39%, 8.90%, and 3.03%,
respectively [5]. We estimated the frequency of C*03:36, C*03:56,
and C*03:86 in Taiwanese population to be approximately 1 in
20,000 to 1 in 30,000 based on our SBT experience from unrelated
volunteer bone marrow donors.
HLA-A and -B antigens have long been regarded as the major
players in the ﬁeld of transplantation, whereas the HLA-C antigen
has only recently emerged as an equally important HLA. HLA-C
antigen mismatching has been associated with increased grade
IIIeIV acute graft versus host disease, treatment-related mortality,
and low disease-free survival [13]. Information about the haplo-
types associated with the unusual HLA-C*03:36, -C*03:56, and
-C*03:86 that we deduced in this study may help in ﬁnding stra-
tegies for appropriate donors in local and international registries
for HLA conﬁrmatory typing purposes, as well as in facilitating
consideration of a minor mismatch option when an HLA fully
matched donor is unavailable.
We think C*03:02:01 may be considered when searching for
minor mismatched unrelated bone marrow hematopoietic stem
cells for transplantation in patients with C*03:36, because of the
nucleotide and amino acid similarities between C*03:36 and
C*03:02:01. Similarly, for patients with C*03:56, C*03:03:01may be
considered if a minor mismatched unrelated donor is intended as
the stem cell source. By contrast, a minor mismatched donor sub-
stitute for a C*03:86 donor is rather difﬁcult to accommodate
because C*03:86 varies from C*03:03:01 and C*01:02:01 by eight
and ﬁve amino acids, respectively.
Acknowledgments
Special thanks are due to all volunteer donors who consented to
our research, and actively participated in the Taiwan Tzu Chi
Marrow Donor Registry for their great love and effort in assisting
needy patients. We are grateful to Dharma Master Cheng Yen for
continuing spiritual support and guidance. We appreciate the
friendship and encouragement of our colleagues. It is their cama-
raderie that drives us forward when we are confronted with ob-
stacles and frustrations.
References
[1] Robinson J, Mistry K, McWilliam H, Lopez R, Parham P, Marsh SG. The IMGT/
HLA database. Nucleic Acids Res 2011;39:D1171e6.
[2] Cao K, Hollenbach J, Shi X, Shi W, Chopek M, Fernández-Viña MA. Analysis of
the frequencies of HLA-A, B, and C alleles and haplotypes in the ﬁve major
ethnic groups of the United States reveals high levels of diversity in these loci
and contrasting distribution patterns in these populations. Hum Immunol
2001;62:1009e30.
[3] Chu CC, Lin M, Nakajima F, Lee HL, Chang SL, Juji T, et al. Diversity of HLA
among Taiwan’s indigenous tribes and the Ivatans in the Philippines. Tissue
Antigens 2001;58:9e18.
[4] Yang KL, Lin PY. Determination of HLA-A, -B and -DRB1 haplotypes based on
allelic homozygosity data in selected bone marrow donors of the Taiwanese
marrow donor registry. Int J Immunogenet 2007;34:385e92.
[5] Yang KL, Chen SP, Shyr MH, Lin PY. High-resolution human leukocyte anti-
gen (HLA) haplotypes and linkage disequilibrium of HLA-B and -C and HLA-
K.-L. Yang et al. / Tzu Chi Medical Journal 25 (2013) 94e97 97DRB1 and -DQB1 alleles in a Taiwanese population. Hum Immunol 2009;70:
269e76.
[6] Shaw CK, Chen LL, Lee A, Lee TD. Distribution of HLA gene and haplotype
frequencies in Taiwan: a comparative study among Min-nan, Hakka, Aborig-
ines and Mainland Chinese. Tissue Antigens 1999;53:51e64.
[7] Chen MJ, Chu CC, Lin PY, Yang KL. Sequence-based typing of a novel HLA-
DRB1*04 allele, DRB1*0461, in a Taiwanese volunteer marrow donor. Int J
Immunogenet 2007;34:269e72.
[8] Chen MJ, Chu CC, Shyr MH, Lin CL, Lin PY, Yang KL. A novel HLA-B allele,
B*5214, detected in a Taiwanese volunteer bone marrow donor using a
sequence-based typing method. Int J Immunogenet 2010;37:39e41.
[9] Wen SH, Lai MJ, Yang KL. Human leukocyte antigen-A, -B, and -DRB1 haplo-
types of cord blood units in the Tzu Chi Taiwan Cord Blood Bank. Hum
Immunol 2008;69:430e6.[10] Lai MJ, Wen SH, Lin YH, Shyr MH, Lin PY, Yang KL. Distributions of human
leukocyte antigen-A, -B, and -DRB1 alleles and haplotypes based on 46,915
Taiwanese donors. Hum Immunol 2010;71:777e82.
[11] Buddaseth S, Müller K, Bade-Doeding C, Blasczyk R, Huyton T. The new allele
HLA-B*35:87 was generated by recombination between HLA-B*35:01 and
B*08:01 in intron 2. Tissue Antigens 2012;79:211e2.
[12] Balas A, Gonzalez-Roiz C, Vargas ML, Garcia-Sánchez F, Vicario JL.
Sequencing of the new HLA-B*44:150 allele suggests recombination
between B*44:02:01:01 and B*07:02:01 alleles. Tissue Antigens 2012;80:
548e9.
[13] Woolfrey A, Klein JP, Haagenson M, Spellman S, Petersdorf E, Oudshoorn M,
et al. HLA-C antigen mismatch is associated with worse outcome in unrelated
donor peripheral blood stem cell transplantation. Biol Blood Marrow Trans-
plant 2011;17:885e92.
